1
|
Guo X, Mao Z, Su D, Jiang Z and Bai L: The
clinical pathological features, diagnosis, treatment and prognosis
of small intestine primary malignant tumors. Med Oncol. 31:9132014.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Hatzaras I, Palesty JA, Abir F, et al:
Small-bowel tumors: Epidemiologic and clinical characteristics of
1260 cases from the Connecticut tumor registry. Arch Surg.
142:229–235. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Wada T, Mizuno K, Itoh K, et al:
Adenosquamous carcinoma of the jejunum. J Gatroenterol. 38:786–790.
2003. View Article : Google Scholar
|
4
|
Cecchini S, Correa-Gallego C, Desphande V,
Ligorio M, Dursun A, Wargo J, Fernàndez-del Castillo C, Warshaw AL
and Ferrone CR: Superior prognostic importance of perineural
invasion vs. lymph node involvement after curative resection of
duodenal adenocarcinoma. J Gastrointest Surg. 16:113–120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Overman MJ, Kopetz S, Lin E, Abbruzzese JL
and Wolff RA: Is there a role for adjuvant therapy in resected
adenocarcinoma of the small intestine. Acta Oncol. 49:474–479.
2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Otten TR, Stein PD, Patel KC, Mustafa S
and Silbergleit A: Thromboembolic disease involving the superior
vena cava and branchiocephalic veins. Chest. 123:809–812. 2003.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Rice TW, Rodriguez RM and Light RW: The
superior vena cava syndrome: Clinical characteristics and evolving
etiology. Medicine (Baltimore). 85:37–42. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Japan Pancreas Society: General Rules for
the Study of Pancreatic Cancer (6th). Kanehara, Tokyo: 2009.
|
9
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM Classification of Malignant Tumours (7th). Hoboken, NJ:
Wiley-Blackwell. 2009.
|
10
|
National Cancer Institute: Common
Terminology Criteria for Adverse Events (CTCAE). version 4.0.
http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdfAccessed.
November 10–2015
|
11
|
Zaanan A, Costes L, Gauthier M, et al:
Chemotherapy of advanced small-bowel adenocarcinoma: A multicenter
AGEO study. Ann Oncol. 21:1786–1798. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Blanco P, Ly S, Beylot Barry M, Laurent F,
Roques X, Doutre M and Beylot C: Surgical treatment of an
endovascular metastatic melanoma of the superior vena cava.
Dermatology. 199:156–157. 1999. View Article : Google Scholar : PubMed/NCBI
|
13
|
Ghattas S, Howle J, Wang W, Kefford R and
Gruenewald S: Intravascular metastatic melanoma: A difficult
diagnosis. Australas J Dermatol. 54:141–143. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Takeda T, Saitoh M and Takeda S: Superior
vena cava syndrome caused by an intravascular thrombosis due to
underlying prostate carcinoma. Intern Med. 47:2007–2009. 2008.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Wang J, Liang J, Wang W, Ouyang H and Wang
L: Malignant thrombosis of the superior vena cava caused by
non-small-cell lung cancer treated with radiation and erlotinib: A
case with complete and prolonged response over 3 years. Onco
Targets Ther. 6:749–753. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Murphy C, Schwalb H, Berlangieri S and Eek
R: Intraluminal superior vena cava metastasis in a patient with
poorly differentiated thyroid carcinoma. J Clin Oncol. April
21–2014.(Epub ahead of print).
|
17
|
Matsuno Y, Takama N, Yasuhara K, Koyano T,
Obayashi T, Sasaki T, Kanesawa N and Kurabayashi M: Long-survival
case of thymic carcinoma with superior vena cava tumor thrombus.
Ann Thorac Surg. 94:1729–1731. 2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Alzand BS, Geyik Z, Dannert R and Cheriex
EC: Superior vena cava syndrome as a complication of colon
carcinoma. Int J Cardiol. 132:e45–e47. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Spittell PC and Hayes DL: Venous
complications after insertion of a transvenous pacemaker. Mayo Clin
Proc. 67:258–265. 1992. View Article : Google Scholar : PubMed/NCBI
|
20
|
Krug H and Zerbe F: Major venous
thrombosis. A complication of transvenous pacemaker electrodes. Br
Heart J. 44:158–161. 1980. View Article : Google Scholar : PubMed/NCBI
|
21
|
Cagir B, Nagy MW, Topham A, Rakinic J and
Fry RD: Adenosquamous carcinoma of the colon, rectum, and anus:
Epidemiology, distribution, and survival characteristics. Dis Colon
Rectum. 42:258–263. 1999. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kim A, Bae YK, Gu MJ, Kim JY, Jang KY, Bae
HI, Lee HJ and Hong SM: Epithelial-mesenchymal transition phenotype
is associated with patient survival in small intestinal
adenocarcinoma. Pathology. 45:567–573. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Lee HJ, Lee OJ, Jang KT, Bae YK, Chung JY,
Eom DW, Kim JM, Yu E and Hong SM: Combined loss of E-cadherin and
aberrant β-catenin protein expression correlates with a poor
prognosis for small intestinal adenocarcinomas. Am J Clin Pathol.
139:167–176. 2013. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kase S, Sugio K, Ymazaki K, Okamoto T,
Yano T and Sugimachi K: Expression of E-cadherin and beta-catenin
in human non-small cell lung cancer and the clinical significance.
Clin Cancer Res. 6:4789–4796. 2000.PubMed/NCBI
|
25
|
Liu S, Liao G, Ding J, Ye K, Zhang Y, Zeng
L and Chen S: Dysregulated expression of snail and E-cadherin
correlates with gastrointestinal stromal tumor metastasis. Eur J
Cancer Prev. 23:329–335. 2014. View Article : Google Scholar : PubMed/NCBI
|
26
|
Fernebro E, Bendahl PO, Dictor M, Persson
A, Fernö M and Nilbert M: Immunohistochemical patterns in rectal
cancer: Application of tissue microarray with prognostic
correlations. Int J Cancer. 111:921–928. 2004. View Article : Google Scholar : PubMed/NCBI
|
27
|
Yang J, Mani SA, Donaher JL, Ramaswamy S,
Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A and
Weinberg RA: Twist, a master regulator of morphogenesis, plays an
essential role in tumor metastasis. Cell. 117:927–939. 2004.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Sorbye H, Dragomir A, Sundström M,
Pfeiffer P, Thunberg U, Bergfors M, Aasebø K, Eide GE, Ponten F,
Qvortrup C and Glimelius B: High BRAF mutation frequency and marked
survival differences in subgroups according to KRAS/BRAF mutation
status and tumor tissue availability in a prospective
population-based metastatic colorectal cancer cohort. PLoS One.
29:e01310462015. View Article : Google Scholar
|